Respiratory Tract Infections Caused by New Influenza A (H1N1)

Gad, Niveen M.; Abu-Zahab, Zakia; Zakzouk, Zeinab
June 2010
Australian Journal of Basic & Applied Sciences;2010, Vol. 4 Issue 6, p1055
Academic Journal
Novel influenza A (H1N1) virus is the pathogen of recent global outbreaks of febrile respiratory infection. Objective: was to describe baseline characteristics, treatment, and outcomes of the majority of patients with confirmed 2009 influenza A (H1N1). Subjects and methods: nasopharyngeal swab or tracheal aspirate were obtained from patients with flu symptoms, from which only patients confirmed of having H1N1 influenza by reverse transcriptase - real time PCR (RT-PCR) were studied. Ninety seven patients (52 males and 45 females) were analyzed for demographic data, symptoms and signs, duration of illness, dose and duration of treatment, and clinical outcomes. Results: all patients were positive for H1N1 by (RT-PCR). 74.2% of them were in age group from 14 and 40. All patients received antivirals and most of them recovered without complications (95/97), with only two complicated. Conclusion: H1N1 is acute respiratory illness which tends to be mild and spread rapidly. Measures is needed for rapid diagnosis, prevent spreading and effective treatment at the appropriate time.


Related Articles

  • Analysis of the effectiveness of interventions used during the 2009 A/H1N1 influenza pandemic. Halder, Nilimesh; Kelso, Joel K.; Milne, George J. // BMC Public Health;2010, Vol. 10 Issue 1, p168 

    Background: Following the emergence of the A/H1N1 2009 influenza pandemic, public health interventions were activated to lessen its potential impact. Computer modelling and simulation can be used to determine the potential effectiveness of the social distancing and antiviral drug therapy...

  • Swine Flu (H1N1) update 2010. Amerena, Vincent C. // eLABORATE;Jan/Feb2010, p116 

    The article provides updated information through January 1, 2010 on the H1N1 influenza. The virus is transmitted from human to human, and countries are no longer required to report cases to the World Health Organization (WHO). Antiviral drug resistance, water contamination of the drug ostelamvir...

  • What Is the Optimal Therapy for Patients with H5N1 Influenza? White, Nicholas J.; Webster, Robert G.; Govorkova, Elena A.; Uyeki, Timothy M. // PLoS Medicine;Jun2009, Vol. 6 Issue 6, p1 

    Background to the debate: In a 2007 article in PLoS Medicine [10], Holger J. Schünemann and colleagues described a new process used by the World Health Organization for rapidly developing clinical management guidelines in emergency situations. These situations include outbreaks of emerging...

  • Editorial Commentary: What Did We Learn From the Emergency Use Authorization of Peramivir in 2009? Pavia, Andrew T. // Clinical Infectious Diseases;Jul2012, Vol. 55 Issue 1, p16 

    The author reflects on the consequences of the pandemics caused by Influenza A (H1N1) virus in 2009 for the patients resistant to the available antiviral drugs and has raised the issue of growing crisis in pharmaceutical development. The reason for this crisis may be due to the leniency of...

  • Antiviral sales boosted as UAE prepares for influenza A (H1N1).  // PharmaWatch: Monthly Review;Jun2009, Vol. 8 Issue 6, p29 

    The article reports on the increase in sales of antiviral agents in preparation for the influenza A (H1N1) in United Arab Emirates (UAE). It notes that H1N1, also known as swine flu, has become a governmental problem nationwide which encourages the ability of a nation to manage communicable...

  • Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009. Lee, Vernon J.; Yap, Jonathan; Tay, Joshua K.; Barr, Ian; Qiuhan Gao; Ho, Hanley J.; Boon Huan Tan; Kelly, Paul M.; Tambyah, Paul A.; Kelso, Anne; Chen, Mark I. // BMC Infectious Diseases;2010, Vol. 10 Issue 1, p164 

    Background: Anti-viral prophylaxis is used to prevent the transmission of influenza. We studied serological confirmation of 2009 Influenza A (H1N1) infections during oseltamivir prophylaxis and after cessation of prophylaxis. Methods: Between 22 Jun and 16 Jul 09, we performed a cohort study in...

  • The New Swine Flu and You.  // Echo Magazine;5/28/2009, Vol. 20 Issue 18, p38 

    The article discuses the questions that health officials attempt to determine in the emergence of the swine flu (H1N1) in the U.S. According to the article, health officials determine the signs and symptoms of the flu and show that the symptoms are just like the seasonal flu that include fever...

  • Influenza pandemics: past, present and future challenges. Flahault, Antoine; Zylberman, Patrick // Public Health Reviews (2107-6952);2010, Vol. 32 Issue 1, p319 

    Influenza epidemics occur regularly and prediction of their conversion to pandemics and their impact is diffi cult. Coordination of efforts on a global scale to control or reduce the impact is fraught with potential for under and overreaction. In light of the 1956 pandemic and more recently the...

  • Diagnosis and Antiviral Intervention Strategies for Mitigating an Influenza Epidemic. Moss, Robert; McCaw, James M.; McVernon, Jodie // PLoS ONE;2011, Vol. 6 Issue 2, p1 

    Background: Many countries have amassed antiviral stockpiles for pandemic preparedness. Despite extensive trial data and modelling studies, it remains unclear how to make optimal use of antiviral stockpiles within the constraints of healthcare infrastructure. Modelling studies informed...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics